Levaquin, known generically as levofloxacin, is an antibiotic drug prescribed for the treatment of bacterial infections especially those affecting the bladder, sinuses, kidneys, skin, and prostate. Levaquin is categorized as a fluoroquinolone antibiotic, and can be used in the prevention of anthrax infection and the plague. Levaquin is also prescribed to patients suffering from bronchitis and pneumonia.
Levaquin is manufactured by Ortho-McNeil-Janssen Pharmaceuticals. The antibiotic was approved by the U.S. Food & Drug Administration in 1996.
Patients who have used Levaquin have suffered from serious tendon, joint, and muscle problems, including the following:
- Tendon rupture
- Tendon inflammation
- Joint immobility
Tendon ruptures as a result of Levaquin use are known to happen more frequently in those patients who are of 60 years of age or older. These tendon ruptures occur most often in the shoulder area, hands, wrists, and the back of the heel, and cause severe pain and immobility.
In addition to tendon deterioration and joint rupture, the use of Levaquin has also been linked to peripheral neuropathy, a serious health condition that causes severe and permanent nerve damage.
If you or someone you know has suffered a debilitating tendon rupture or tendonitis due to the use of Levaquin, compensation for such undue suffering is deserved. Pharmaceutical product liability attorneys at Carey Danis & Lowe fight for consumer protection, and provide clients with expert legal advice to win much-deserved justice against negligent pharmaceutical giants. For more information about filing a Levaquin lawsuit, contact an experienced Levaquin lawyer at Carey Danis & Lowe today.
Manufacturer: Janssen Pharms
FDA Approval: December 20,1996 to treat bacterial infections of the skin, sinuses, kidneys, bladder, or prostate
Generic Availability: Ocotober 15, 2004